UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypersensitivity Reactions to Docetaxel: Retrospective Evaluation and Development of a Desensitization Protocol

International archives of allergy and immunology, 2011-01, Vol.156 (3), p.320-324

2011

Volltextzugriff (PDF)

New Drug and Possible New Toxicity - Squamous Cell Carcinoma Following Imatinib in Patients with Gastrointestinal Stromal Tumors

Anticancer research, 2016-11, Vol.36 (11), p.6201-6204

2016

Volltextzugriff (PDF)

Mitomycin–C-Induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: Cumulative Toxicity of an Old Drug in a New Era

Clinical colorectal cancer, 2011-06, Vol.10 (2), p.142-145

2011

Volltextzugriff (PDF)

Neurofibromatosis type 1 and GIST: is there a correlation?

Anticancer research, 2014-10, Vol.34 (10), p.5609-5612

2014

Volltextzugriff (PDF)

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2014-02, Vol.73 (2), p.373-380

2014

Volltextzugriff (PDF)

Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4240-4246

2010

Volltextzugriff (PDF)

Role of Pregabalin in Treatment of Oxaliplatin-induced Sensory Neuropathy

Anticancer research, 2010-07, Vol.30 (7), p.2927-2933

2010

Volltextzugriff (PDF)

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.485-497

2021

Volltextzugriff (PDF)

Assessing Risk and Mortality of Venous Thromboembolism in Pancreatic Cancer Patients

Anticancer research, 2010-10, Vol.30 (10), p.4261-4264

2010

Volltextzugriff (PDF)

Increased Prevalence of Dihydropyrimidine Dehydrogenase Deficiency in African-Americans Compared with Caucasians

Clinical cancer research, 2006-09, Vol.12 (18), p.5491-5495

2006

Volltextzugriff (PDF)

Secondary Tumors of the Pancreas: A Case Series

Anticancer research, 2012-04, Vol.32 (4), p.1449-1452

2012

Volltextzugriff (PDF)

A DPYD Variant (Y186C) Specific to Individuals of African Descent in a Patient With Life-Threatening 5-FU Toxic Effects: Potential for an Individualized Medicine Approach

Mayo Clinic proceedings, 2014, Vol.89 (1), p.131-136

2014

Volltextzugriff (PDF)

Oxaliplatin-induced Pancreatitis: A Case Series

Anticancer research, 2010-12, Vol.30 (12), p.5113-5115

2010

Volltextzugriff (PDF)

Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2011-12, Vol.68 (6), p.1565-1573

2011

Volltextzugriff (PDF)

Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study

Anticancer research, 2010-07, Vol.30 (7), p.2905-2909

2010

Volltextzugriff (PDF)

Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature

Cancer chemotherapy and pharmacology, 2009-05, Vol.63 (6), p.1017-1022

2009

Volltextzugriff (PDF)

Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer

Cancer chemotherapy and pharmacology, 2008-03, Vol.61 (3), p.349-354

2008

Volltextzugriff (PDF)

The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience

Anticancer research, 2011-09, Vol.31 (9), p.2971-2974

2011

Volltextzugriff (PDF)

Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea

Cancer chemotherapy and pharmacology, 2017-12, Vol.80 (6), p.1055-1062

2017

Volltextzugriff (PDF)

Capecitabine-related cardiotoxicity: recognition and management

The Journal of supportive oncology, 2008-01, Vol.6 (1), p.41

2008

Volltextzugriff (PDF)

Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States

World journal of gastroenterology : WJG, 2009-09, Vol.15 (35), p.4415-4422

2009

Volltextzugriff (PDF)

Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas

The cancer journal (Sudbury, Mass.), 2009-07, Vol.15 (4), p.339-343

2009

Volltextzugriff (PDF)

Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase

The cancer journal (Sudbury, Mass.), 2007-07, Vol.13 (4), p.247-256

2007

Volltextzugriff (PDF)

Dihydropyrimidine dehydrogenase gene (DPYD) polymorphism among Caucasian and non-Caucasian patients with 5-FU- and capecitabine-related toxicity using full sequencing of DPYD

Cancer genomics & proteomics, 2013-03, Vol.10 (2), p.89-92

Saif, Muhammad Wasif

2013

Volltextzugriff (PDF)

Oxaliplatin-Induced Immune Thrombocytopenia: Another Cumulative Dose-Dependent Side Effect?

Clinical colorectal cancer, 2009-10, Vol.8 (4), p.220-224

2009

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(95)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(95)
Life Sciences & Biomedicine
(88)
Science & Technology
(88)
Middle Aged
(61)
Male
(58)
Aged
(54)
Oncology
(45)
Adult
(37)
Pancreatic Neoplasms - Drug Therapy
(34)
Deoxycytidine - Analogs & Derivatives
(32)
Gastroenterology & Hepatology
(30)
Capecitabine
(23)
Treatment Outcome
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Deoxycytidine - Adverse Effects
(20)
Fluorouracil - Adverse Effects
(20)
Fluorouracil - Analogs & Derivatives
(20)
Pancreatic Neoplasms
(20)
Pharmacology & Pharmacy
(20)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypersensitivity Reactions to Docetaxel: Retrospective Evaluation and Development of a Desensitization Protocol

New Drug and Possible New Toxicity - Squamous Cell Carcinoma Following Imatinib in Patients with Gastrointestinal Stromal Tumors

Mitomycin–C-Induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: Cumulative Toxicity of an Old Drug in a New Era

Neurofibromatosis type 1 and GIST: is there a correlation?

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer

Role of Pregabalin in Treatment of Oxaliplatin-induced Sensory Neuropathy

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

Assessing Risk and Mortality of Venous Thromboembolism in Pancreatic Cancer Patients

Increased Prevalence of Dihydropyrimidine Dehydrogenase Deficiency in African-Americans Compared with Caucasians

Secondary Tumors of the Pancreas: A Case Series

A DPYD Variant (Y186C) Specific to Individuals of African Descent in a Patient With Life-Threatening 5-FU Toxic Effects: Potential for an Individualized Medicine Approach

Oxaliplatin-induced Pancreatitis: A Case Series

Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors

Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study

Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature

Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer

The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience

Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea

Capecitabine-related cardiotoxicity: recognition and management

Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States

Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas

Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase

Dihydropyrimidine dehydrogenase gene (DPYD) polymorphism among Caucasian and non-Caucasian patients with 5-FU- and capecitabine-related toxicity using full sequencing of DPYD

Oxaliplatin-Induced Immune Thrombocytopenia: Another Cumulative Dose-Dependent Side Effect?

Aktive Filter

Suchergebnisse filtern